A Better Vaccination For COVID-19?

[Wake-up!]

A major drawback of the RNA vaccines developed by Pfizer and Moderna is that they pose the problem of antibody dependent enhancement (ADE) when your own antibodies attack your lungs and other internal organs. ADE is usually a delayed reaction. And ADE is beginning to occur among vaccinated populations. These are the adverse reactions and deaths you may be hearing about. ADE strikes younger populations. And according to some reports, vaccine-induced antibodies against COVID-19 are not providing lasting immunity.

One answer to the above problems of ADE is to design therapies that target T-cells rather than antibodies. T-cells are known to protect against severe infection and re-infection. T-cell memory provides lasting immunity. T-cell directed vaccines stimulate clearance of viruses and avoid ADE illnesses and adverse reactions.

There already is a proven safe and effective vaccine that protects against COVID-19 via activation of T-cells, the Bacille Calmette-Guerin (BCG) vaccine for tuberculosis, another infectious lung disease.  BCG is derived from a mycobacterium found in cattle. It is a "live" but attenuated bacterium vaccination. The BCG vaccine is so safe it has been approved for use with neonates, children, and adults for almost 100 years. The BCG vaccine also confers immunity against Staphylococcus and Candida organisms, and is useful in preventing multiple sclerosis and cancer.

Here is a detailed article on the politics of pushing the antibody vaccine over the T-cell vaccine, with much more information on how both work in the body; https://www.lewrockwell.com/2021/03/no_author/if-you-absolutely-must-vaccinate-against-covid-19-out-of-fear-or-coercion-hold-out-for-this-already-proven-vaccine/